Ask where the 10,000-step target comes from and most people guess "doctors" or "the WHO". The real answer is an advertising department. In 1965, a Japanese company launched a pedometer called manpo-kei — literally "10,000-step meter" — partly because the character for 10,000 (万) looks a bit like a person walking. The number was chosen to sell pedometers. It worked so well it became global health folklore.
None of which makes walking less good for you. It just means the specific number deserves a look.
Once accelerometers got cheap, researchers could finally test the slogan on large groups. The pattern replicates across studies and continents: the health benefit curve rises steeply from sedentary levels, keeps climbing through the middle, and flattens somewhere around 6,000–8,000 steps for older adults and roughly 8,000–10,000 for younger ones. A widely cited 2019 study of older women found mortality benefits leveling off near 7,500 steps. Meta-analyses since have kept landing in that neighborhood.
Two details matter more than the headline number. The biggest jump in the whole curve is at the bottom — going from 2,000 to 4,000 steps does more for you, proportionally, than going from 8,000 to 10,000. And pace counts: some of the benefit tracks with cadence, not just totals. Thirty brisk minutes beats the same steps accumulated by shuffling to the fridge.
If you're mostly sedentary: any structured walk is a win, and consistency beats ambition. A 20-minute session is roughly 2,000–2,500 steps — measure yours once with the pedometer and you'll know your own numbers instead of estimates. If you're moderately active, 7,000–8,000 daily steps captures most of what 10,000 offers. And if you like 10,000 as a round number that keeps you honest — keep it. It's a fine target. It's just marketing that happened to point in a healthy direction.
The trap to skip: treating a missed target as failure. The curve doesn't have a cliff at 9,999. It's a curve.